YZYanyang Zhang

Yanyang Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yanyang Zhang has a total of 91 co-authors. Here are the top co-authors by number of shared publications:

  • Yonghao Guo

    Institute of Immunization Prevention and Planning, Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China

    4 shared publications
  • Jun Li

    Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China

    3 shared publications
  • Xiaoxiao Zhang

    Institute of Immunization Prevention and Planning, Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China

    3 shared publications
  • Binghui Du

    Institute of Immunization Prevention and Planning, Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China

    2 shared publications
  • Mingyu Zhang

    Henan Center for Disease Control and Prevention, Zhengzhou, People’s Republic of China

    2 shared publications
  • Xiaoxiao Zhang

    Institute for Immunization Prevention and Programme, Henan Provincial Center for Disease Control and Prevention

    2 shared publications

Latest Publications

  • Open Access

    Delayed Recognition of Measles Cluster Outbreaks in a High-Vaccination-Coverage Setting: Epidemiological and Clinical Characteristics of Primary and Index Cases with Different Immune Statuses, Henan Province, China, 2025

    by Jun Li, Binghui Du, Zheng Tian, Xiaoli Wang, Jing Li, Xiaoxiao Zhang, Yonghao Guo, Yanyang Zhang

    Background/Objectives: Under high measles vaccination coverage, breakthrough infections often present with mild, atypical features that may delay outbreak recognition. We characterized measles cluster outbreaks in a high-coverage setting, focusing on the interval between primary-case and index-case onset as a measure of delayed outbreak recognition. Methods: We investigated three measles cluster outbreaks comprising 66 laboratory-confirmed cases reported in Henan Province, China, in 2025, using field investigation and laboratory testing, and compared clinical manifestations by immunization status; because of profound age differences between immunization groups, comparisons were presented descriptively. Results: The interval from primary- to index-case onset ranged from 4 to 15 days, representing an upper-bound estimate of the recognition delay. All three primary cases had received two doses of measles-containing vaccine (MCV) and presented with low-grade fever and localized rash, whereas none of the four index cases had an MCV history and all had peak temperatures ≥39 °C. Among the 21 infected close contacts identified from 100 screened close contacts, 84.6% (11/13) of vaccinated (≥1 dose) individuals were asymptomatic or mild, versus 37.5% (3/8) of unvaccinated or status-unknown individuals. Among cases with documented immunization history, pneumonia (17.4% vs. 37.5%) and hospitalization (43.5% vs. 62.5%) were less frequent in vaccinated than in unvaccinated cases; these unadjusted differences were confounded by age and are presented descriptively. Conclusions: Breakthrough measles infections in high-coverage settings have atypical presentation and mild symptoms. Such infections may lead to unrecognized community transmission. Surveillance should incorporate active case finding for atypical presentations in high-coverage high-density settings.

  • Open Access

    Dynamic characteristics of Neisseria meningitidis carriage among new students in boarding martial arts schools: a longitudinal follow-up study

    by Jun Li, Yingying Liu, Jiangnan Kong, Xiaoli Wang, Tian Tian, Xiangyang Zhang, Xiaoxiao Zhang, Yanfang Ji, Yonghao Guo, Qian Liu, et al.

    Objective: This study aimed to characterize the dynamic patterns of Neisseria meningitidis (Nm) carriage, identify factors influencing Nm acquisition and clearance, and provide empirical evidence for understanding the epidemiological mechanisms of Nm carriage and for developing targeted prevention strategies. Methods: A prospective cohort of 60 new entrants was established at a boarding martial arts school in Dengfeng City from February to December 2025. Oropharyngeal swabs were collected at regular intervals and subjected to laboratory testing. A hidden Markov model (HMM) was applied to estimate acquisition and clearance rates of Nm, and proportional hazards models were used to assess the effects of covariates on these rates. Results: A total of 13 follow-up visits and samplings were completed. The Nm carriage prevalence ranged from 30.00 to 93.75%, showing an overall upward trend, with serogroups B and X being predominant. During the observation period, 52.54% (31/59) of positive carriers exhibited ≥2 carriage episodes, and 35.59% (21/59) carried ≥2 serogroups over time. The mean carriage duration was estimated at 7.38 months (95% CI: 4.18–13.01). For Nm acquisition, individuals aged ≥15 years had a higher acquisition rate than those aged <15 years (HR = 2.01, 95% CI: 0.99–4.08), and those with a smoking history showed a higher acquisition rate than non-smokers (HR = 1.48, 95% CI: 0.76–2.91), although the latter difference was not statistically significant. For Nm clearance, age ≥15 years (HR = 4.40, 95% CI: 1.49–13.00) and fever in the past week (HR = 4.16, 95% CI: 1.36–12.75) were significantly associated with higher clearance rates. Smoking history (HR = 3.39, 95% CI: 0.92–12.53) and antibiotic use (HR = 2.58, 95% CI: 0.74–9.05) also suggested potential associations with increased clearance, but these did not reach statistical significance. Conclusion: New entrants in this boarding martial arts school exhibited a high risk of Nm carriage, with prolonged average carriage duration and frequent serogroup switching during carriage episodes. Age ≥15 years and recent fever were significantly associated with enhanced Nm clearance. These findings underscore the need for strengthened health surveillance and behavioral interventions to reduce the risk of persistent carriage and onward transmission in such congregate settings.

  • Open Access

    Human metapneumovirus in central China, 2024–2025: epidemiology, co-infections, and temporal dynamics

    by Guo Yonghao, Liu Qian, Ding Baolong, Seng Minghua, Zhao Sheng, Kong Jiangnan, Dou Qiaohua, Wang Wenhui, Feng Daxing, Lv Wanyu, et al.

  • Open Access

    Factors Associated with Prescription-to-Vaccination Conversion and Timeliness: A Real-World Analysis

    by Mengru Xiao, Jun Li, Shejun He, Meiqiong Xiang, Xiaohong Dong, Xiaoyang Wang, Xiaoxiao Zhang, Yonghao Guo, Yanyang Zhang

    Background: This study evaluated vaccine prescription conversion and identified associated factors in Henan Province, China, during 2025. Methods: The study was conducted in Lingbao City, Henan Province. All vaccine prescriptions issued in 2025 were collected, and vaccination status was linked through the Henan Provincial Immunization Information Management System. Subgroup analyses were stratified by vaccine type (NIP vs. non-NIP). Univariate analyses used χ2, Mann–Whitney U, and Kruskal–Wallis H tests. Multivariable analyses employed Firth-corrected logistic regression for conversion behavior, and mixed-effects models with random intercepts for patient ID for conversion timeliness, analyzed using a two-part model. All analyses were performed using R software (version 4.5.3). Results: Among 50,887 prescriptions, the overall conversion rate was 13.8%. NIP vaccines had a higher conversion rate than non-NIP vaccines (76.8% vs. 12.5%, p < 0.001) and a higher same-day conversion rate (13.9% vs. 7.4%; χ2 = 59.585, p < 0.001), but longer delays among non-same-day conversions (23 vs. 4 days). Manual prescriptions were associated with significantly higher conversion in both NIP (OR = 3.913) and non-NIP (OR = 37.720) subgroups. Vaccination clinics were associated with a nearly 20-fold higher odds (OR = 19.386). Interaction analyses showed manual prescriptions were more strongly associated with conversion and shorter delays in older adults, and had stronger associations with conversion for non-NIP vaccines (χ2 = 22.275, p < 0.001). Vaccination clinics were most strongly associated with conversion in children (ΔP = 0.130); however, the improvement in same-day conversion among older adults was relatively smaller, suggesting additional barriers beyond clinic availability may exist in this population. Conclusions: Manual prescriptions and vaccination clinics were associated with higher vaccine prescription conversion, with particularly pronounced effects on non-NIP vaccines. Older adults exhibited the lowest conversion rates. In parallel with promoting electronic prescriptions, co-issuing paper prescriptions is recommended, particularly for non-NIP vaccines and older adults.

  • Open Access

    Influenza Vaccination Willingness, Uptake, and Behavioral Drivers Among Adults Aged ≥60 Years in Henan Province: A BeSD-Based Survey with Registry Follow-Up

    by Jun Li, Xinyang Li, Kaichao Yang, Yuxia Yun, Yanyan Yang, Lijun Deng, Zunshui Li, Xiaoyang Wang, Xiaoxiao Zhang, Lubin Shi, et al.

    Objectives: To identify factors influencing influenza vaccination willingness and uptake among adults aged ≥60 years in Henan Province and to evaluate the effect of a brief educational intervention on vaccination willingness and behavior. Methods: In September 2024, a cross-sectional survey based on the Behavioral and Social Drivers (BeSD) framework was conducted among adults aged ≥60 years across five counties in Henan. For participants without baseline willingness, a 3 min one-on-one educational intervention was delivered. In May 2025, following the end of the 2024–2025 influenza vaccination season (which runs from 1 October to 31 March in Henan Province), we retrieved vaccination records for all participants from the Henan Provincial Immunization Information System. This system captures all influenza vaccinations administered at designated vaccination clinics across the province. To ensure completeness for doses administered outside the provincial system (e.g., in other provinces or at private healthcare facilities), we conducted telephone follow-up interviews with all participants whose baseline vaccination intention was inconsistent with their actual vaccination behavior (i.e., willing but unvaccinated or unwilling but vaccinated). During these interviews, for those who reported receiving the vaccine outside Henan Province or at private facilities, we inquired about the specific date and location of vaccination to supplement the registry data. We also explored the reasons behind the intention–behavior discrepancy. For these participants, we requested vaccination certificates or other supporting documentation to confirm their vaccination status. Results: Baseline vaccination willingness was 68.20% (1630/2390), whereas the actual vaccination rate was only 6.95% (166/2390), yielding a willingness-to-behavior conversion rate of 9.51% (155/1630) among those with baseline willingness. Of the 760 participants without baseline willingness, 543 (71.45%) completed the 3 min one-on-one instant educational intervention and the follow-up assessment; the remaining 217 were excluded due to refusal or loss to follow-up. Among these 543 completers, 46 (8.47%) became willing to vaccinate, and eight (1.47%) were subsequently vaccinated. Multivariate analysis identified the social processes dimension as the strongest correlate of both willingness (OR = 1.38 per 1-point increase, 95% CI: 1.33–1.44) and uptake (OR = 1.12, 95% CI: 1.03–1.22). Urban residence was associated with higher willingness (OR = 1.41, 95% CI: 1.12–1.78) and higher uptake (OR = 1.64, 95% CI: 1.11–2.42). Current smokers had a significantly lower uptake than never smokers (OR = 0.43, 95% CI: 0.22–0.85). Among the 11 participants without baseline willingness who were eventually vaccinated (eight from the intervention group and three from the non-intervention group), family/friend influence (63.64%, 7/11) and physician recommendation (36.36%, 4/11) were the primary drivers. For those with willingness but no action (n = 1475), the main barriers were perceived good health (33.29%), high vaccine cost (27.12%), and lack of time (26.31%). Conclusions: Influenza vaccination among older adults in Henan exhibits a “high willingness, low conversion” pattern, with social processes as the strongest driver bridging the intention–behavior gap. A brief educational intervention improved willingness but failed to translate into meaningful uptake, underscoring that knowledge transfer alone is insufficient. We recommend a multi-component strategy that (1) mobilizes family members and community doctors as trusted vaccine advocates; (2) leverages family and village doctor networks to reduce urban–rural disparities; (3) counters the “perceived good health” barrier with age-specific risk communication; and (4) integrates vaccine recommendations into routine care for high-risk groups, particularly frequent outpatient attendees and smokers.

  • Open Access

    Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6–7 Months: A Phase 4, Randomized, Controlled Trial

    by Yanhui Xiao, Xue Guo, Min Zhang, Yaping Chen, Yanyang Zhang, Xiaoqing Yu, Linyun Luo, Haiping Chen, Weichai Xu, Haibo Liu, et al.

    Objective: To assess the immunogenicity and safety of the enterovirus 71 vaccine (Vero cell) (EV71 vaccine) and trivalent split-virion influenza vaccine (IIV3). Methods: Healthy infants aged 6–7 months were recruited from Zhejiang Province, Henan Province, and Guizhou Province and randomly assigned to the simultaneous vaccination group, EV71 group, and IIV3 group at a ratio of 1:1:1. Then, 3 mL blood samples were collected before vaccination and 28 days after the second dose of vaccine. Cytopathic effect inhibition assay was used to detect EV71 neutralization antibody, and cytopathic effect inhibition assay was used to detect influenza virus antibody. Results: A total of 378 infants were enrolled and received the first dose of vaccine and were included in the safety analysis, and 350 infants were involved in the immunogenicity analysis. The adverse events rates were 31.75%, 28.57%, and 34.13% in the simultaneous vaccination group, EV71 group, and IIV3 group (p > 0.05), respectively. No vaccine-related serious adverse events were reported. After two doses of EV71 vaccine, the seroconversion rates of EV71 neutralizing antibody were 98.26% and 97.37% in the simultaneous vaccination group and the EV71 group, respectively. After two doses of IIV3, the simultaneous vaccination group and the IIV3 group, respectively, had seroconversion rates of 80.00% and 86.78% for H1N1 antibody, 99.13% and 98.35% for H3N2 antibody, and 76.52% and 80.99% for B antibody. There was no statistically significant difference in the seroconversion rates of influenza virus antibodies between groups (p > 0.05). Conclusions: The coadministration of EV71 vaccine and IIV3 has good safety and immunogenicity in infants aged 6–7 months.


  • Open Access

    Epidemiological survey and genetic characterization of type 3 vaccine-derived poliovirus isolated from a patient with four doses of inactivated polio vaccine in Henan Province, China

    by Mingyu Zhang, Jianhui Yang, Yiran Bai, Hui Zhu, Changshuang Wang, Lu Zhang, Jin Xu, Mingxia Lu, Xiaoxiao Zhang, Zhanpei Xiao, et al.

    Background: Vaccine-derived poliovirus (VDPV) is a potential threat to polio eradication because they can reintroduce into the general population and cause paralytic polio outbreaks, a phenomenon that has recently emerged as a prominent public health concern at the end of global polio eradication. This study aimed to describe the epidemiology and genetic characteristics of the first VDPV identified from a patient with acute flaccid paralysis (AFP), with four doses of inactivated polio vaccine immunization in Henan Province, China in 2017. Methods: The patient was diagnosed with type 3 VDPV. Subsequently, a series of epidemiological approaches was implemented, including a retrospective search of AFP cases, rate of vaccination assessment, study of contacts, and supplementary immunization activities. Fecal samples were collected, viral isolation was performed, and the viral isolates were characterized using full-length genomic sequencing and bioinformatic analysis. Results: Phylogenetic analysis showed that the viral isolates from the patient were different from other reported genetic clusters of type 3 VDPV worldwide. They were identified as a Sabin 3/Sabin 1 recombinant VDPV with a crossover site in the P2 region. Nucleotide substitutions, including U → C (472) and C → U (2493), have been identified, both of which are frequently observed as reversion mutations in neurovirulent type 3 poliovirus. A unique aspect of this case is that the patient had been vaccinated with four doses of inactive polio vaccine, and the serum neutralizing antibody for Sabin types 1 and 3 were 1∶16 and 1∶512, respectively. Thus, the patient was speculated to have been infected with type 3 VDPV, and the virus continued to replicate and be excreted for at least 41 d. Conclusions: The existence of this kind of virus in human population is a serious risk and poses a severe challenge in maintaining a polio-free status in China. To the best of our knowledge, this is the first report of VDPV identified in the Henan province of China. Our results highlight the importance of maintaining a high-level vaccination rate and highly sensitive AFP case surveillance system in intercepting VDPV transmission.


  • Open Access

    The impact of universal live attenuated hepatitis A vaccines in Henan, China, 2005–2018

    by Yonghao Guo, Lu Zhang, Daxing Feng, Sheng Zhao, Qian Liu, Jin Xu, Mingxia Lu, Jun Li, Yanyang Zhang, Wanshen Guo


  • Open Access

    Automated cell-based luminescence assay for profiling antiviral compound activity against enteroviruses

    by Mingyu Zhang, Yong Zhang, Yan Wang, Wanyu Lv, Yanyang Zhang

    We describe the development, optimisation, and validation of an automated, cell-based and high-throughput screening assay using existing luminescence-based ATPlite reagents for identifying antiviral compounds that inhibit enterovirus replication. Antiviral efficacy was determined by measuring the ATP levels in cells that were protected from the viral cytopathic effect (CPE) by the antiviral compounds pleconaril and rupintrivir. CPE-based assay conditions were optimised at a cell density of 5000 cells/well and a viral infection dose of 100 CCID50 in 384-well plates. The assay exhibited excellent robustness, with Z′-factor values between 0.75 and 0.82, coefficients of variation between 0.33% and 1.45%, and signal-to-background ratios ranging from 6.92 to 22.6 when testing three enterovirus A71 isolates circulating in China. The assay was also suitable for screening other picornaviruses, such as poliovirus, coxsackievirus, echovirus, and parechovirus.